AHR
protein-codingaryl hydrocarbon receptor, the group of Basic helix-loop-helix proteins|PAS domain containing
Gene summary
The protein encoded by this gene is a ligand-activated helix-loop-helix transcription factor involved in the regulation of biological responses to planar aromatic hydrocarbons. This receptor has been shown to regulate xenobiotic-metabolizing enzymes such as cytochrome P450. Before ligand binding, the encoded protein is sequestered in the cytoplasm; upon ligand binding, this protein moves to the nucleus and stimulates transcription of target genes. [provided by RefSeq, Sep 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~429.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032689
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0044203
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0975805
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032689
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032689
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0019200
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AHR variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001621.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 131 | 3 | 134 | |||
| missense | 285 | 9 | 3 | 297 | ||
| nonsense | 2 | 2 | 4 | |||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 1 | 3 | |||
| splice donor/acceptor (+/-2bp) | 2 | 1 | 1 | 4 | ||
| Total | 6 | 3 | 288 | 140 | 6 | 443 |
Highest pathogenic variant AF is 0.000003718237
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001612.1 | 11 | MANE Select | |
| Ensembl | ENSP00000242057.4 | 11 | MANE Select | |
| Ensembl | ENSP00000436466.1 | 11 | Standard | |
| Ensembl | ENSP00000495987.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Cushing,s syndrome - Homo sapiens (human)
- Th17 cell differentiation - Homo sapiens (human)
- Integrated Breast Cancer Pathway
- Adipogenesis
- Aryl Hydrocarbon Receptor
Biological Process
- blood vessel development
- regulation of transcription, DNA-templated
- regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
- xenobiotic metabolic process
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- TFIID-class transcription factor complex binding
- transcription coactivator binding
- DNA binding
- DNA-binding transcription factor activity
Cellular Component
- nucleus
- nucleoplasm
- transcription factor complex
- cytoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000242057
- Coding exons
- 11
- Length
- 47531
- Individuals with no LoFs
- 125737
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 11
- Defined
- 125748
- p
- 0.0000437
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.735 | 403 | 447 | 0.902 | 0.0000223 | 5619 |
| Missense (PolyPhen) | 56 | 101.24 | 0.55314 | 1270 | ||
| Synonymous | -1.01 | 179 | 163 | 1.10 | 0.00000842 | 1573 |
| Loss of Function | 5.64 | 2 | 40.9 | 0.0489 | 0.00000238 | 449 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000065 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00019 | 0.00018 | rare |
| European (Non-Finnish) | 0.000027 | 0.000026 | rare |
| South Asian | 0.000066 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Ligand-activated transcriptional activator. Binds to the XRE promoter region of genes it activates. Activates the expression of multiple phase I and II xenobiotic chemical metabolizing enzyme genes (such as the CYP1A1 gene). Mediates biochemical and toxic effects of halogenated aromatic hydrocarbons. Involved in cell-cycle regulation. Likely to play an important role in the development and maturation of many tissues. Regulates the circadian clock by inhibiting the basal and circadian expression of the core circadian component PER1. Inhibits PER1 by repressing the CLOCK-ARNTL/BMAL1 heterodimer mediated transcriptional activation of PER1. The heterodimer ARNT:AHR binds to core DNA sequence 5'-TGCGTG-3' within the dioxin response element (DRE) of target gene promoters and activates their transcription (PubMed:28602820). {ECO:0000269|PubMed:10395741, ECO:0000269|PubMed:28602820, ECO:0000269|PubMed:7961644}.;
Recessive Scores
- pRec
- 0.740
Intolerance Scores
- LoFtool
- 0.393
- RVIS EVS
- -0.31
- RVIS percentile EVS
- 32.23
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.714
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |